Header Logo

Connection

FASIHA KANWAL to Liver Transplantation

Back to Details
This is a "connection" page, showing publications FASIHA KANWAL has written about Liver Transplantation.
FASIHA KANWAL
Connection Strength
4.903
Liver Transplantation
  1. Unseen foe: The financial toxicity of liver transplantation. Liver Transpl. 2024 09 01; 30(9):873-874.
    View in: PubMed
    Score: 0.448
  2. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.373
  3. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int. 2021 Oct; 34(10):1971-1983.
    View in: PubMed
    Score: 0.372
  4. Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease. JAMA Intern Med. 2021 07 01; 181(7):949-959.
    View in: PubMed
    Score: 0.367
  5. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
    View in: PubMed
    Score: 0.341
  6. Communication and trust: Critically important to eliminate disparities in liver transplantation. Liver Transpl. 2016 07; 22(7):881-3.
    View in: PubMed
    Score: 0.259
  7. Potentially curative treatment in patients with hepatocellular cancer--results from the liver cancer research network. Aliment Pharmacol Ther. 2012 Aug; 36(3):257-65.
    View in: PubMed
    Score: 0.196
  8. Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy. Liver Transpl. 2026 Jun 01; 32(6):823-829.
    View in: PubMed
    Score: 0.124
  9. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):169-77.
    View in: PubMed
    Score: 0.117
  10. Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 09 01; 80(3):742-753.
    View in: PubMed
    Score: 0.111
  11. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl. 2003 Dec; 9(12):1312-9.
    View in: PubMed
    Score: 0.108
  12. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes. Cancer Med. 2023 07; 12(14):15011-15025.
    View in: PubMed
    Score: 0.105
  13. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
    View in: PubMed
    Score: 0.105
  14. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
    View in: PubMed
    Score: 0.104
  15. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
    View in: PubMed
    Score: 0.104
  16. Posttransplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transpl. 2023 07 01; 29(7):777-780.
    View in: PubMed
    Score: 0.103
  17. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
    View in: PubMed
    Score: 0.103
  18. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4.
    View in: PubMed
    Score: 0.101
  19. Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692.
    View in: PubMed
    Score: 0.100
  20. Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review. Liver Transpl. 2022 12; 28(12):1865-1875.
    View in: PubMed
    Score: 0.100
  21. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25.
    View in: PubMed
    Score: 0.099
  22. Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1.
    View in: PubMed
    Score: 0.099
  23. The chosen and the unchosen: How eligibility for liver transplant influences the lived experiences of patients with advanced liver disease. Soc Sci Med. 2022 07; 305:115113.
    View in: PubMed
    Score: 0.098
  24. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
    View in: PubMed
    Score: 0.097
  25. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
    View in: PubMed
    Score: 0.097
  26. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544.
    View in: PubMed
    Score: 0.095
  27. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver Transpl. 2022 01; 28(1):123-126.
    View in: PubMed
    Score: 0.094
  28. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.093
  29. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int. 2020 08; 33(8):925-935.
    View in: PubMed
    Score: 0.085
  30. Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2019 03; 17(4):739-747.e8.
    View in: PubMed
    Score: 0.075
  31. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2018 06; 67(6):2085-2095.
    View in: PubMed
    Score: 0.073
  32. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list. Hepatology. 2017 03; 65(3):777-788.
    View in: PubMed
    Score: 0.067
  33. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004 Sep; 99(9):1726-32.
    View in: PubMed
    Score: 0.029
  34. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003 Jul; 9(7):672-81.
    View in: PubMed
    Score: 0.026
  35. Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10.
    View in: PubMed
    Score: 0.017
  36. Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis. Dig Dis Sci. 2017 01; 62(1):84-92.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.